The economic burden of noncervical human papillomavirus disease in the United States
- 31 May 2008
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (5) , 500.e1-500.e7
- https://doi.org/10.1016/j.ajog.2008.03.064
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Review of the economic and quality-of-life burden of cervical human papillomavirus diseaseAmerican Journal of Obstetrics and Gynecology, 2007
- Carcinoma of the VulvaInternational Journal of Gynecology & Obstetrics, 2006
- Chapter 13: Current findings from prophylactic HPV vaccine trialsVaccine, 2006
- Cost Analysis of Neonatal Circumcision in a Large Health Maintenance OrganizationJournal of Urology, 2006
- Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention, 2005
- Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the USPharmacoEconomics, 2005
- A Cost-Utility Analysis of Neonatal CircumcisionMedical Decision Making, 2004
- The Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000Perspectives on Sexual and Reproductive Health, 2004
- The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-upEuropean Journal Of Cancer, 2001
- Human Papillomavirus in Squamous Cell Carcinoma of the Vulva by Polymerase Chain ReactionObstetrics & Gynecology, 1997